{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

MissionIRNewsBreaks – Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine

June 17, 2026Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. “Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur,” reads a recent article.


June 17, 2026Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) and may include paid advertising.


TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Receives Additional DefendAir Order From Tier-1 Defense Customer

June 17, 2026ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional order for its DefendAir Net Pod system from a second business unit within a Tier-1 Israeli-based global defense company. The order is intended to support integration of the DefendAir Net Pod into the customer’s autonomous ground-based Counter-UAS platform and includes dedicated engineering integration services from ParaZero.


States Proceed with AI Regulations Despite Trump’s Opposition

June 17, 2026Despite a warning from President Donald Trump earlier this year urging states to avoid regulating AI, state lawmakers across the country are continuing to pursue their own rules governing the rapidly expanding technology. Major tech companies like D-Wave Quantum Inc.


AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Robotics Deployment at SAPU Bio Sterile Manufacturing Facility

June 17, 2026Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics subsidiary, announced the advancement of Phase 2 objectives under its joint development collaboration with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the deployment of PUR-E, an autonomous clean room support robot, within SAPU Bio’s OEB-5 sterile injectable cGMP facility. The deployment expands the initiative beyond Phase 1 materials logistics operations and into sterile manufacturing and clean room environments, where TechForce and Oncotelic are evaluating robotics, automation and AI-driven technologies to support regulated pharmaceutical workflows.


TechMediaBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Positioned to Benefit From Growing Demand for AI Infrastructure Automation

June 17, 2026Nightfood Holdings (OTCQB: NGTF) operating through TechForce Robotics, is featured in a new AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is increasing demand for advanced automation, robotics and precision manufacturing solutions. The report highlights TechForce’s recent partnership with Jiun Jiang (“JJ Enterprise”) to advance AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics, positioning the company alongside major AI ecosystem participants including Super Micro Computer Inc.


CFTC Clears Path for ‘True’ Crypto Perpetual Futures

June 17, 2026CNW PocketChange Exploring the concepts, products and innovations influencing currencies, digital assets and global finance. CFTC issued no-action relief allowing exchanges to convert certain perpetual-style digital commodity futures into true perpetual futures.


NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances AI-Powered GMP Manufacturing Platform

June 17, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced the completion of key Phase 2 objectives in its manufacturing automation initiative with TechForce Robotics, advancing commercialization of an AI-powered good manufacturing practices manufacturing services platform at SAPU Bio, the company’s 45%-owned sterile injectable cGMP manufacturing joint venture. The Phase 2 deployment expands the capabilities of Oncotelic’s proprietary PDAOAI(TM) platform across sterile manufacturing operations, electronic batch records, GMP workflow execution, cleanroom monitoring and autonomous materials movement.